To evaluate potential role of HSP90 in the pathogenesis of lipid metabolic disorders, we measured the hepatic HSP90α and HSP90β levels in human specimens from 20 subjects with NAFLD (Table S1). The gene discussed is HSP90AA1; the disease is metabolic dysfunction-associated steatotic liver disease.